UBE2H activators comprise a category of molecules that enhance the enzymatic activity of UBE2H, a ubiquitin-conjugating enzyme crucial to the ubiquitin-proteasome system (UPS). Unlike inhibitors, activators facilitate the catalytic efficiency with which UBE2H transfers ubiquitin to substrate proteins. This action is typically achieved through the stabilization of the enzyme in an active conformation, the enhancement of ubiquitin-thioester bond formation, or the promotion of interactions between UBE2H and ubiquitin ligase enzymes (E3s), which are essential for the specificity of ubiquitin transfer. The fine-tuning of UBE2H activity by these activators has important implications for the regulation of the UPS, which is responsible for the controlled degradation and modulation of key proteins within the cell, affecting numerous cellular functions and maintaining protein homeostasis.
The development of UBE2H activators often involves high-throughput screening to identify potential compounds that increase the activity of the enzyme, followed by structure-activity relationship (SAR) studies to optimize their efficacy. These compounds may bind to sites distinct from the enzyme's active site, known as allosteric sites, to induce conformational changes that promote a more active form of UBE2H. Alternatively, they may directly engage with the active site to facilitate the enzyme's interaction with ubiquitin or an E3 ligase. The molecular design of UBE2H activators is informed by detailed knowledge of the enzyme's structure and the dynamics of its interaction with its substrates and partners. By elucidating the mechanisms through which these activators operate, researchers can obtain valuable insights into the fundamental processes that govern enzyme catalysis and specificity within the ubiquitination pathway.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
A p53 inhibitor. By inhibiting p53-mediated apoptosis, it could increase the cellular reliance on ubiquitination for protein degradation. | ||||||
L-Lysine | 56-87-1 | sc-207804 sc-207804A sc-207804B | 25 g 100 g 1 kg | $95.00 $263.00 $529.00 | ||
As a substrate for ubiquitination, increased levels might stimulate UBE2H activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can alter gene expression, potentially upregulating UBE2H. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
cAMP agonist, which can activate protein kinase A (PKA). PKA may potentially enhance the ubiquitination process. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
PDE inhibitor that elevates cAMP levels, which indirectly can enhance the ubiquitination process through PKA. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Has been shown to influence the ubiquitin-proteasome system. It may indirectly boost UBE2H activity by stimulating the need for ubiquitination. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Can alter metal homeostasis in cells, which might stimulate UBE2H activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
An analog of cAMP that can activate PKA, potentially promoting ubiquitination and indirectly UBE2H activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Known to influence various cellular pathways, including the ubiquitin-proteasome system, which might indirectly upregulate UBE2H. | ||||||